Literature DB >> 28949811

Characterization of Maternal and Fetal CYP3A-Mediated Progesterone Metabolism.

Sara K Quinney1, Tara Benjamin2, Xiaomei Zheng1, Avinash S Patil2.   

Abstract

INTRODUCTION: Progesterone is critical for maintaining pregnancy and onset of labor. We evaluated CYP450-mediated progesterone meta-bolism, specifically the contribution of CYP3A isoforms.
MATERIALS AND METHODS: In vitro progesterone metabolism was characterized in human liver microsomes (HLMs) with and without selective cytochrome P450 inhibitors and in recombinant CYP3A4, CYP3A5, and CYP3A7. 6β-hydroxyprogesterone (6β-OHP) and 16α-hydroxyprogesterone (16α-OHP) metabolites were quantified by HPLC/UV and fit to the Michaelis-Menten equation to determine Km and Vmax. The effect of CYP3A5 expression on progesterone clearance was determined by in vitro in vivo extrapolation.
RESULTS: Ketoconazole inhibited formation of both 6β-OHP and 16α-OHP more than 95%. 6β-OHP and 16α-OHP were both produced by CYP3A4 (2.3 and 1.3 µL/min/pmol, respectively) to a greater extent than by CYP3A5 (0.09 and 0.003 µL/min/pmol) and CYP3A7 (0.004 and 0.003 µL/min/pmol).
CONCLUSIONS: Maternal clearance of progesterone by hepatic CYP450's is driven primarily by CYP3A4, with limited contributions from CYP3A5 and CYP3A7.

Entities:  

Keywords:  16α-hydroxyprogesterone (PubChem CID: 243761); 6β-hydroxyprogesterone (PubChem CID: 200149); Chemical compounds studied in this article are Progesterone (PubChem CID: 5994); Progesterone; cytochrome P450; fetal; metabolism; pharmacokinetics

Mesh:

Substances:

Year:  2017        PMID: 28949811      PMCID: PMC5704987          DOI: 10.1080/15513815.2017.1354411

Source DB:  PubMed          Journal:  Fetal Pediatr Pathol        ISSN: 1551-3815            Impact factor:   0.958


  41 in total

1.  Progesterone and testosterone hydroxylation by cytochromes P450 2C19, 2C9, and 3A4 in human liver microsomes.

Authors:  H Yamazaki; T Shimada
Journal:  Arch Biochem Biophys       Date:  1997-10-01       Impact factor: 4.013

2.  Prediction of in vivo drug clearance from in vitro data. I: impact of inter-individual variability.

Authors:  E M Howgate; K Rowland Yeo; N J Proctor; G T Tucker; A Rostami-Hodjegan
Journal:  Xenobiotica       Date:  2006-06       Impact factor: 1.908

3.  Identification of CYP3A7 for glyburide metabolism in human fetal livers.

Authors:  Diana L Shuster; Linda J Risler; Bhagwat Prasad; Justina C Calamia; Jenna L Voellinger; Edward J Kelly; Jashvant D Unadkat; Mary F Hebert; Danny D Shen; Kenneth E Thummel; Qingcheng Mao
Journal:  Biochem Pharmacol       Date:  2014-10-22       Impact factor: 5.858

Review 4.  Genetic contribution to variable human CYP3A-mediated metabolism.

Authors:  Jatinder K Lamba; Yvonne S Lin; Erin G Schuetz; Kenneth E Thummel
Journal:  Adv Drug Deliv Rev       Date:  2002-11-18       Impact factor: 15.470

5.  Variability of CYP3A7 expression in human fetal liver.

Authors:  J Steven Leeder; Roger Gaedigk; Kenda A Marcucci; Andrea Gaedigk; Carrie A Vyhlidal; Bradley P Schindel; Robin E Pearce
Journal:  J Pharmacol Exp Ther       Date:  2005-04-21       Impact factor: 4.030

Review 6.  The involvement of progesterone in the onset of human labour.

Authors:  Shirley Astle; Donna M Slater; Steven Thornton
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2003-06-10       Impact factor: 2.435

7.  Progesterone metabolism in hepatic microsomes. Effect of the cytochrome P-450 inhibitor, ketoconazole, and the NADPH 5 alpha-reductase inhibitor, 4-MA, upon the metabolic profile in human, monkey, dog, and rat.

Authors:  D C Swinney
Journal:  Drug Metab Dispos       Date:  1990 Nov-Dec       Impact factor: 3.922

8.  Aromatase is the major enzyme metabolizing buprenorphine in human placenta.

Authors:  Sujal V Deshmukh; Tatiana N Nanovskaya; Mahmoud S Ahmed
Journal:  J Pharmacol Exp Ther       Date:  2003-06-13       Impact factor: 4.030

9.  A Semi-Mechanistic Metabolism Model of CYP3A Substrates in Pregnancy: Predicting Changes in Midazolam and Nifedipine Pharmacokinetics.

Authors:  S K Quinney; A N Mohamed; M F Hebert; D M Haas; S Clark; J G Umans; S N Caritis; L Li
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2012-09-26

10.  A PBPK Model to Predict Disposition of CYP3A-Metabolized Drugs in Pregnant Women: Verification and Discerning the Site of CYP3A Induction.

Authors:  A B Ke; S C Nallani; P Zhao; A Rostami-Hodjegan; J D Unadkat
Journal:  CPT Pharmacometrics Syst Pharmacol       Date:  2012-09-26
View more
  5 in total

Review 1.  Neonatal cytochrome P450 CYP3A7: A comprehensive review of its role in development, disease, and xenobiotic metabolism.

Authors:  Haixing Li; Jed N Lampe
Journal:  Arch Biochem Biophys       Date:  2019-08-22       Impact factor: 4.013

Review 2.  Secretory products of the corpus luteum and preeclampsia.

Authors:  María M Pereira; Monica Mainigi; Jerome F Strauss
Journal:  Hum Reprod Update       Date:  2021-06-22       Impact factor: 15.610

3.  Alterations in endogenous progesterone metabolism associated with spontaneous very preterm delivery.

Authors:  Avinash S Patil; Nilesh W Gaikwad; Chad A Grotegut; Shelley D Dowden; David M Haas
Journal:  Hum Reprod Open       Date:  2020-04-06

4.  Early pregnancy maternal progesterone administration alters pituitary and testis function and steroid profile in male fetuses.

Authors:  Katarzyna J Siemienowicz; Yili Wang; Magda Marečková; Junko Nio-Kobayashi; Paul A Fowler; Mick T Rae; W Colin Duncan
Journal:  Sci Rep       Date:  2020-12-14       Impact factor: 4.379

Review 5.  Progesterone: A Steroid with Wide Range of Effects in Physiology as Well as Human Medicine.

Authors:  Lucie Kolatorova; Jana Vitku; Josef Suchopar; Martin Hill; Antonin Parizek
Journal:  Int J Mol Sci       Date:  2022-07-20       Impact factor: 6.208

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.